Cargando…

The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism

Parkinson's disease (PD) is a common neurodegenerative disorder, characterized by motor impairment and a wide range of non-motor symptoms, including sleep disorders and cognitive and affective deficits. In this study, we used a mouse model of PD based on 6-hydroxydopamine (6-OHDA) to examine th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masini, D, Lopes-Aguiar, C, Bonito-Oliva, A, Papadia, D, Andersson, R, Fisahn, A, Fisone, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416699/ https://www.ncbi.nlm.nih.gov/pubmed/28398338 http://dx.doi.org/10.1038/tp.2017.58

Ejemplares similares

A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2014)

Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson’s Disease
por: Masini, Débora, et al.
Publicado: (2018)

On the Role of Histamine Receptors in the Regulation of Circadian Rhythms
por: Rozov, Stanislav V., et al.
Publicado: (2015)

Evaluation of Thioperamide Effects Using Rat's Trachea Model
por: Chiu, Feng-Hsiang, et al.
Publicado: (2013)

Thioperamide treats neonatal hypoxic-ischemic encephalopathy by postsynaptic H1 receptors
por: Jia, Feiyong, et al.
Publicado: (2013)

Activation of CREB‐mediated autophagy by thioperamide ameliorates β‐amyloid pathology and cognition in Alzheimer’s disease
por: Wang, Jiangong, et al.
Publicado: (2021)

Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2011)

L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission
por: Feyder, Michael, et al.
Publicado: (2011)

Sleep and circadian rhythms in Parkinson’s disease and preclinical models
por: Hunt, Jeremy, et al.
Publicado: (2022)

Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease
por: Vallée, Alexandre, et al.
Publicado: (2020)

Sleep Disorders in Rodent Models of Parkinson’s Disease
por: Medeiros, Daniel de Castro, et al.
Publicado: (2019)

On the Role of Adenosine A2A Receptor Gene Transcriptional Regulation in Parkinson’s Disease
por: Falconi, Anastasia, et al.
Publicado: (2019)

Histamine antagonists promote cancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2023)

Circadian Rhythm Abnormalities in Parkinson’s Disease from Humans to Flies and Back
por: De Lazzari, Federica, et al.
Publicado: (2018)

Octopamine Rescues Endurance and Climbing Speed in Drosophila Clk(out) Mutants with Circadian Rhythm Disruption
por: Safdar, Maryam, et al.
Publicado: (2023)

Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?
por: De Benedetto, Anna, et al.
Publicado: (2015)

New Insight in Histamine Functions
por: Sgambellone, Silvia, et al.
Publicado: (2022)

Circadian rhythms and diabetes
por: Kurose, Takeshi, et al.
Publicado: (2011)

Circadian rhythms in parasites
por: Rijo-Ferreira, Filipa, et al.
Publicado: (2017)

Circadian Rhythms in Attention
por: Valdez, Pablo
Publicado: (2019)

Overview of Circadian Rhythms
por: Vitaterna, Martha Hotz, et al.
Publicado: (2001)

Focus on circadian rhythms
por: Harmer, Stacey L, et al.
Publicado: (2022)

A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms
por: Masini, Débora, et al.
Publicado: (2021)

Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson’s Disease
por: Kim, Jeongah, et al.
Publicado: (2022)

Circadian rhythm entrainment of the jewel wasp, Nasonia vitripennis, by antagonistic interactions of multiple spectral inputs
por: Wang, Yifan, et al.
Publicado: (2023)

Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists.
por: Van der Ven, L. T., et al.
Publicado: (1993)

Retinal Ganglion Cells and Circadian Rhythms in Alzheimer’s Disease, Parkinson’s Disease, and Beyond
por: La Morgia, Chiara, et al.
Publicado: (2017)

[(11)C]Doxepin binding to histamine H1 receptors in living human brain: reproducibility during attentive waking and circadian rhythm
por: Shibuya, Katsuhiko, et al.
Publicado: (2012)

Circadian rhythms and memory formation: regulation by chromatin remodeling
por: Sahar, Saurabh, et al.
Publicado: (2012)

A Selective Histamine H(4) Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia
por: Dettori, Ilaria, et al.
Publicado: (2018)

Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease
por: Kim, Jeongah, et al.
Publicado: (2022)

Circadian Rhythms and Obesity in Mammals
por: Froy, Oren
Publicado: (2012)

Circadian Rhythms in Socializing Propensity
por: Zhang, Cheng, et al.
Publicado: (2015)

Circadian rhythms in mitochondrial respiration
por: de Goede, Paul, et al.
Publicado: (2018)

Circadian Rhythm and Alzheimer’s Disease
por: Homolak, Jan, et al.
Publicado: (2018)

Nocturia and Reversed Circadian Rhythms
por: Knapp, M. S.
Publicado: (1969)

Air Travel and Circadian Rhythm
por: Mills, J. N.
Publicado: (1973)

Editorial: Circadian Rhythms and Metabolism
por: Challet, Etienne, et al.
Publicado: (2017)

Editorial: Disorders of Circadian Rhythms
por: Chi-Castañeda, Donají, et al.
Publicado: (2020)

Circadian rhythm and atherosclerosis (Review)
por: Zhang, Zaiqiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2gim65a61g2embtk31g3or2atc